Andrew Elagizi
Overview
Explore the profile of Andrew Elagizi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
757
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tutor A, OKeefe E, Lavie C, Elagizi A, Milani R, OKeefe J
Prog Cardiovasc Dis
. 2024 Mar;
84:19-26.
PMID: 38547956
Even with substantial progress in primary and secondary prevention, cardiovascular disease (CVD) persists as a major cause of mortality and morbidity globally. Omega-3 polyunsaturated fatty acids (Ω-3 PUFAs) have gained...
2.
Gersh F, OKeefe J, Elagizi A, Lavie C, Laukkanen J
Prog Cardiovasc Dis
. 2024 Jan;
84:60-67.
PMID: 38272338
A large body of scientific research accumulated over the past twenty years documents the cardiovascular (CV) benefits of estradiol (E2) and progesterone (P4) in reproductive aged women. In contrast, accelerated...
3.
OKeefe E, Lavie C, Elagizi A, Milani R, Laukkanen J
J Am Coll Cardiol
. 2023 Nov;
82(21):e201-e202.
PMID: 37968024
No abstract available.
4.
Elagizi A, Gersh F, Lavie C, Laukkanen J, OKeefe J
Eur Heart J
. 2023 Aug;
45(2):139-141.
PMID: 37556598
No abstract available.
5.
Elagizi A, Lavie C, Gersh F, OKeefe J
Mayo Clin Proc
. 2023 Jul;
98(7):1098-1099.
PMID: 37419577
No abstract available.
6.
Stewart M, Elagizi A, Gilliland Y
Curr Opin Cardiol
. 2023 Apr;
38(5):405-414.
PMID: 37115813
Purpose Of Review: The current article reviews obstructive forms of hypertrophic cardiomyopathy and associated morphologic cardiac abnormalities. It focuses on echocardiographic imaging of the left ventricular (LV) outflow tract obstruction,...
7.
Carbone S, Elagizi A, Lavie C
Eur J Heart Fail
. 2023 Mar;
25(5):711-713.
PMID: 36974755
No abstract available.
8.
Ventura H, Elagizi A, Lavie C
J Am Coll Cardiol
. 2023 Mar;
81(12):1162-1164.
PMID: 36948732
No abstract available.
9.
Rodriguez D, Lavie C, Elagizi A, Milani R
Nutrients
. 2022 Dec;
14(23).
PMID: 36501174
Twenty percent of deaths in the United States are secondary to cardiovascular diseases (CVD). In patients with hyperlipidemia and hypertriglyceridemia, studies have shown high atherosclerotic CVD (ASCVD) event rates despite...
10.
Carbone S, Lavie C, Elagizi A, Arena R, Ventura H
Cardiol Clin
. 2022 Apr;
40(2):209-218.
PMID: 35465895
Overweight and obesity adversely impact cardiac structure and function, affecting systolic and diastolic ventricular function. Epidemiologic studies have documented an obesity paradox in large heart failure cohorts, where overweight and...